In the BioHarmony Drug Report Database
Ella, Esmya (ulipristal) is a small molecule pharmaceutical. Ulipristal was first approved as Ella on 2010-08-13. It has been approved in Europe to treat leiomyoma. The pharmaceutical is active against progesterone receptor. Ella’s patents are valid until 2030-06-12 (FDA).
Image (chem structure or protein)